These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23998981)

  • 41. Adverse effects of proton pump inhibitor drugs: clues and conclusions.
    McCarthy DM
    Curr Opin Gastroenterol; 2010 Nov; 26(6):624-31. PubMed ID: 20802330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
    Frazzoni L; Fuccio L; Frazzoni M
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staying healthy while using PPIs. Be mindful of risks for fracture, low B12, and a spike in stomach acid.
    Harv Health Lett; 2015 Feb; 40(4):7. PubMed ID: 26223055
    [No Abstract]   [Full Text] [Related]  

  • 44. What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?
    Devitt J; Lyon C; Swanson SB; DeSanto K
    J Fam Pract; 2019 Apr; 68(3):E18-E19. PubMed ID: 31039222
    [No Abstract]   [Full Text] [Related]  

  • 45. [Long-term use of proton pump inhibitors: who needs prophylaxis?].
    Scheurlen M
    Internist (Berl); 2013 Mar; 54(3):366-72. PubMed ID: 23404267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton pump inhibitors: potential adverse effects.
    Abraham NS
    Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
    Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
    [No Abstract]   [Full Text] [Related]  

  • 50. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.
    Attwood SE; Ell C; Galmiche JP; Fiocca R; Hatlebakk JG; Hasselgren B; Långström G; Jahreskog M; Eklund S; Lind T; Lundell L
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1162-74. PubMed ID: 25858519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
    Çelebi A; Yılmaz H
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S71-S72. PubMed ID: 29199173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 58. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.
    Bavishi C; Dupont HL
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1269-81. PubMed ID: 21999643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS
    Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.